Predictions of Systemic, Intracellular, and Lung Concentrations of Azithromycin With Different Dosing Regimens Used in COVID‐19 Clinical Trials

• मुख्य लेखकों: Jim H. Hughes (लेखक), Kevin Sweeney (लेखक), Sima Ahadieh (लेखक), Daniele Ouellet (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Wiley, 2020-08-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Azithromycin (AZ), a broad‐spectrum macrolide antibiotic, is being investigated in patients with coronavirus disease 2019 (COVID‐19). A population pharmacokinetic model was implemented to predict lung, intracellular poly/mononuclear cell (peripheral blood monocyte (PBM)/polymorphonuclear leukocyte (...